ASCO Education

Self-Evaluation: Non-Small Cell Lung Cancer (NSCLC) - Locally Advanced

TRANSCRIPT Welcome to the Self-Evaluation episode of the ASCO University weekly podcast. My name is Apar Kishor Ganti, and I'm the Associate Director for Clinical Research and the co-leader of the Thoracic Oncology Service at the University of Nebraska Medical Center, Fred and Pamela Buffett Cancer Center. Today, we feature a self-evaluation question on locally advanced non-small cell lung cancer. I will begin by reading the question stem. A 58-year-old man with a 50-pack year history of...

Self-Evaluation: Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

TRANSCRIPT Welcome to the Self-Evaluation episode of the ASCO University weekly podcast. My name is Apar Kishor Ganti, and I'm the Associate Director for Clinical Research and the co-leader of the Thoracic Oncology Service at the University of Nebraska Medical Center, Fred and Pamela Buffett Cancer Center. Today, we feature a self-evaluation question on locally advanced non-small cell lung cancer. I will begin by reading the question stem. A 58-year-old man with a 50-pack year history of...

Self-Evaluation: Non-Small Cell Lung Cancer (NSCLC) - Locally Advanced

TRANSCRIPT Welcome to the Self-Evaluation episode of the ASCO University weekly podcast. My name is Apar Kishor Ganti, and I'm the Associate Director for Clinical Research and the co-leader of the Thoracic Oncology Service at the University of Nebraska Medical Center, Fred and Pamela Buffett Cancer Center. Today, we feature a self-evaluation question on locally advanced non-small cell lung cancer. I will begin by reading the question stem. A 58-year-old man with a 50-pack year history of...

ASCO Guideline: Metastatic Pancreatic Cancer

TRANSCRIPT [MUSIC PLAYING] Welcome to the ASCO Guidelines episode of the ASCO University weekly podcast. My name is Alexander Drilon, and I'm the clinical director of the early drug development service at Memorial Sloan Kettering Cancer Center and editorial board member for ASCO University. Today we feature an ASCO guideline published in the Journal of Clinical Oncology. The episode you are about to hear was originally aired on the ASCO Guidelines podcast series. The ASCO Guidelines po...

Self-Evaluation: Treatment of Multiple Myeloma Plasma Cell Leukemia

Annual Meeting 2018 - ASCO Voices: Did You Ever Know That You're My Hero

2018 Annual Meeting raised the curtain on a new session type: ASCO Voices. These noncompete session feature presentations no longer than 7 minutes each and bring a variety of perspectives to the stage to share stories on oncology, medicine, and the world. From big ideas to personal passions, ASCO Voices present stories that differ significantly from the remainder of session types available at Annual Meeting.  

Self-Evaluation: Gastric Cancer Diagnosis

[MUSIC PLAYING] Welcome to the self-evaluation episode of the ASCO University Weekly Podcast. My name is Teviah Sachs, and I am an Assistant Professor of Surgery at the Boston University School of Medicine and Surgical Oncologist at Boston Medical Center. Today we will feature a self-evaluation question on the treatment of gastric cancer. And we begin by reading the question stem. A 53-year-old Hispanic woman presents to her primary care physician after noticing black tarry stools for th...

ASCO Guideline: Practical Assessment and Management of Vulnerabilities

[MUSIC PLAYING] Welcome to the ASCO Guidelines episode of the ASCO University Weekly Podcast. My name is Alexander Drilon, and I'm the Clinical Director of the Early Drug Development Service at Memorial Sloan Kettering Cancer Center and editorial board member for ASCO University. Today, we feature an ASCO guideline published in the Journal of Clinical Oncology. The episode you are about to hear was originally aired on the ASCO Guidelines Podcast Series. The ASCO Guidelines Podcast Series...

ASCO Guideline: Practical Assessment and Management of Vulnerabilities

[MUSIC PLAYING] Welcome to the ASCO Guidelines episode of the ASCO University Weekly Podcast. My name is Alexander Drilon, and I'm the Clinical Director of the Early Drug Development Service at Memorial Sloan Kettering Cancer Center and editorial board member for ASCO University. Today, we feature an ASCO guideline published in the Journal of Clinical Oncology. The episode you are about to hear was originally aired on the ASCO Guidelines Podcast Series. The ASCO Guidelines Podcast Series...

Self-Evaluation: Small Cell Lung Cancer

Welcome to the self-evaluation episode of the ASCO University weekly podcast. My name is Shadia Jalal, and I am a thoracic oncologist at Indiana University. Today, we feature a self-evaluation question on the treatment of limited-stage small-cell lung cancer. And we begin by the question. A 58-year-old man with a 40-pack-year history of cigarette smoking is found to have a spiculated 2.1-centimeter left upper lobe mass on CAT scan imaging that was performed for a suspected pneumonia. His p...

Recently Approved Drugs: Nivolumab for patients with metastatic small cell lung cancer

Victoria Lai is a thoracic medical oncologist at Memorial Sloan Kettering Cancer Center with a clinical and research focus on small cell lung cancer and other pulmonary neuroendocrine tumors.  She conducts clinical trials that aim to elucidate the underlying biology of small cell lung cancer in order to develop new biomarkers and treatments options to improve patient outcomes.   TRANSCRIPT [MUSIC PLAYING] Welcome to the recent approvals episode of the ASCO University weekly podcast. ...

Recently Approved Drugs: Nivolumab for patients with metastatic small cell lung cancer

Victoria Lai is a thoracic medical oncologist at Memorial Sloan Kettering Cancer Center with a clinical and research focus on small cell lung cancer and other pulmonary neuroendocrine tumors.  She conducts clinical trials that aim to elucidate the underlying biology of small cell lung cancer in order to develop new biomarkers and treatments options to improve patient outcomes.   TRANSCRIPT [MUSIC PLAYING] Welcome to the recent approvals episode of the ASCO University weekly podcast. ...

ASCO Guideline: Palliative Care in the Global Setting

Shadia Jalal, MD, Assistant Professor of Clinical Medicine in the Department of Medicine, Division of Hematology/Oncology at Indiana University School of Medicine discusses updated guideline for palliative care in the global setting. TRANSCRIPT Welcome to the ASCO Guidelines episode of the ASCO University weekly podcast. My name is Alexander Drilon, and I am the clinical director of the Early Drug Development Service at Memorial Sloan Kettering Cancer Center and editorial board member f...

Annual Meeting 2018 - ASCO Voices: Heroes, Mentors, and Hope

2018 Annual Meeting raised the curtain on a new session type: ASCO Voices. These noncompete session feature presentations no longer than 7 minutes each and bring a variety of perspectives to the stage to share stories on oncology, medicine, and the world. From big ideas to personal passions, ASCO Voices present stories that differ significantly from the remainder of session types available at Annual Meeting. Dr. Trevor Bayliss is an oncologist in Pittsfield, Massachusetts and is affiliated...

Special Episode: Immunotherapies

Michael A. Postow, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses a variety of immunotherapy treatments and how they increase an immune response against tumors.

Self-Evaluation: Breast - Partial Mastectomy Follow-Up

Rachel Freedman, MD, MPH- Assistant Professor, Medicine, Harvard Medical School, Dana-Farber Cancer Institute presents a self-assessment question from an ASCO University course focusing on the treatment breast cancer.  AUDIO TRANSCRIPT Welcome to the self-evaluation episode of the ASCO University weekly podcast. My name is Rachel Friedman, and I'm a medical oncologist and clinical researcher in the Breast Oncology Center at Dana-Farber Cancer Institute. Today, we feature a self-evaluatio...

Self-Evaluation: Breast - Partial Mastectomy Follow-Up

Rachel Freedman, MD, MPH- Assistant Professor, Medicine, Harvard Medical School, Dana-Farber Cancer Institute presents a self-assessment question from an ASCO University course focusing on the treatment breast cancer.  AUDIO TRANSCRIPT Welcome to the self-evaluation episode of the ASCO University weekly podcast. My name is Rachel Friedman, and I'm a medical oncologist and clinical researcher in the Breast Oncology Center at Dana-Farber Cancer Institute. Today, we feature a self-evaluatio...

Special Episode: Non-Hodgkin Lymphoma

Karen M. Winkfield, MD, PhD, Associate Professor of Radiation Oncology, Comprehensive Cancer Center at Wake Forest Baptist Health discusses identifying factors associated with prognosis and staging in a MALT lymphoma and how to identify factors predicting local failure following H Pylori eradication therapy. 

Annual Meeting 2018 - ASCO Voices: The Call

2018 Annual Meeting raised the curtain on a new session type: ASCO Voices. These noncompete session feature presentations no longer than 7 minutes each and bring a variety of perspectives to the stage to share stories on oncology, medicine, and the world. From big ideas to personal passions, ASCO Voices present stories that differ significantly from the remainder of session types available at Annual Meeting. Dr. Loehrer is director of the Indiana University Melvin and Bren Simon Cancer Cen...

Recently Approved Drugs: Lutetium Lu 177 dotatate for treatment of GEP-NETs

Dr. Jonathan Strosberg, section chief of the Neuroendocrine Tumor Division of the Moffitt Cancer Center, discusses the recent FDA approval of Lutetium Lu 177 dotatate for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

ASCO Guideline: Antiemetics Guideline for Treatment-Induced Nausea and Vomiting

An interview with Dr. Paul Hesketh from Lahey Hospital and Medical Center on the antiemetics guideline update published in 2017. The guideline update expands the recommendations to include olanzapine and neurokinin 1 receptor antagonists. Read the full guideline at www.asco.org/supportive-care-guidelines

Self-Evaluation: Breast

Rachel Freedman, MD, MPH- Assistant Professor, Medicine, Harvard Medical School, Dana-Farber Cancer Institute, presents a self-assessment question from an ASCO University course focusing on the treatment breast cancer.   

Recently Approved Drugs: Durvalumab for patients with stage III Non-Small Cell Lung Cancers (NSCLC)

Rami Manochakian, M.D., a thoracic clinical oncologist at the Mayo Clinic in Florida, presents information on the recently approved drug in oncology, durvalumab for patients with stage III Non-Small Cell Lung Cancers (NSCLC) after the completion of radiation therapy.

Self-Evaluation: Special histologies - lymphoma: Primary CNS, appropriate first line therapy for newly diagnosed primary CNS lymphoma

Self-Evaluation: Karen M. Winkfield, MD, PhD, Associate Professor of Radiation Oncology, Comprehensive Cancer Center at Wake Forest Baptist Health, presents a self-assessment question from an ASCO University course focusing on, the appropriate first line therapy for newly diagnosed primary CNS lymphoma.

ASCO Guideline: Fertility Preservation in Patients with Cancer

An interview with Dr. Alison W. Loren of Perelman School of Medicine of the University of Pennsylvania on the ASCO guideline update which provides current recommendations about fertility preservation for adults and children with cancer. Read the full guideline at www.asco.org/survivorship-guidelines

ASCO Guideline: Fertility Preservation in Patients with Cancer

An interview with Dr. Alison W. Loren of Perelman School of Medicine of the University of Pennsylvania on the ASCO guideline update which provides current recommendations about fertility preservation for adults and children with cancer. Read the full guideline at www.asco.org/survivorship-guidelines

Self-Evaluation: EGFR Mutation

Self-Evaluation: Apar Kishor Ganti, MD, Professor in the Department of Internal Medicine, Division of Oncology/Hematology, and Associate Director of Clinical Research at the Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, presents a self-evaluation question from an ASCO University course focusing on the treatment of an EGFR Mutation.  

Self-Evaluation: EGFR Mutation

Self-Evaluation: Apar Kishor Ganti, MD, Professor in the Department of Internal Medicine, Division of Oncology/Hematology, and Associate Director of Clinical Research at the Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, presents a self-evaluation question from an ASCO University course focusing on the treatment of an EGFR Mutation.  

Recently Approved Drugs: Olaparib for germline BRCA-mutated metastatic breast cancer

Dr. Linh Alejandro, a clinical oncology pharmacist at the University of California, San Diego Health Systems discusses the approval of olaparib for germline BRCA-mutated metastatic breast cancer.

ASCO Guidelines: Outpatient Management of Fever and Neutropenia

An interview with Dr. Christopher Flowers of Emory University School of Medicine on the ASCO/IDSA clinical practice guideline which provides updated recommendations on outpatient management of fever and neutropenia in patients with cancer. Read the full guideline at www.asco.org/supportive-care-guidelines

ASCO Guidelines: Outpatient Management of Fever and Neutropenia

An interview with Dr. Christopher Flowers of Emory University School of Medicine on the ASCO/IDSA clinical practice guideline which provides updated recommendations on outpatient management of fever and neutropenia in patients with cancer. Read the full guideline at www.asco.org/supportive-care-guidelines

Self-Evaluation: NSCLC Treatment Metastatic

Shadia Jalal, MD, Assistant Professor of Clinical Medicine Department of Medicine Division of Hematology/Oncology Indiana University School of Medicine, presents a self-evaluation question from an ASCO University course focusing on the treatment of non-small cell lung cancers.

Adjuvant Treatment in Melanoma: Recent Advances

Dr. Rodrigo Munhoz, medical oncologist at Centro de Oncologia- Hospital Sírio-Libanês in Sao Paolo, Brazil, discusses recent advances in the adjuvant therapy for patients with high-risk melanoma

Recently Approved Drugs: Blinatumomab for B-cell precursor ALL

Alex Ganetsky, PharmD, BCOP, oncology clinical pharmacy specialist at the Hospital of the University of Pennsylvania in Philadelphia discusses the approval to blinatumomab (Blincyto, Amgen Inc.) for the treatment of adult and pediatric patients with B-cell precursor acute lymphoblastic leukemia (ALL) in first or second complete remission with minimal residual disease (MRD) greater than or equal to 0.1%.

Guidelines: Management of Immune-Related Adverse Events

An interview with Dr. Bryan Schneider of the University of Michigan on the ASCO clinical practice guideline to increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events in patients treated with immune checkpoint inhibitor (ICPi) therapy. Read the full guideline at www.asco.org/supportive-care-guidelines 

Guidelines: Management of Immune-Related Adverse Events

An interview with Dr. Bryan Schneider of the University of Michigan on the ASCO clinical practice guideline to increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events in patients treated with immune checkpoint inhibitor (ICPi) therapy. Read the full guideline at www.asco.org/supportive-care-guidelines 

Treatment Effects & Transition to Survivorship for AYA Patients

Cindy Schwartz, MD, MPH, is an accomplished oncologist who brings 35 years of experience, passion and expertise in the areas of Hodgkin lymphoma, osteosarcoma and childhood cancer survivorship.

EHR Chemotherapy Error: Breast Cancer

Dr. Carolyn Hendricks is a board certified medical oncologist specializing in breast cancer. She received her medical degree from Johns Hopkins University School of Medicine and has been in practice for more than 20 years. 

Continuity of Care for AYAs

Dr. Larissa Nekhlyudov is a board-certified general internist and Medical Director of Primary Care Associates, Longwood. Dr. Nekhlyudov practiced internal medicine at Harvard Vanguard Medical Associates for over 15 years. In this episode she discusses the importance of effective communication between the primary care physician & oncologist for AYA patients diagnosed with cancer.

Self-Evaluation: Clinical Trials Informed Consent Process

Dr. Suresh Ramalingam, professor of hematology and medical oncology at Emory University and Deputy Director at the Winship Cancer Institute of Emory University, presents a self-evaluation question on Clinical Trials: Informed Consent

Self-Evaluation: Clinical Trials

Dr. Suresh Ramalingam, professor of hematology and medical oncology at Emory University and Deputy Director at the Winship Cancer Institute of Emory University, presents a self-evaluation question on clinical research methodologies, clinical trials, phase III.

Self-Evaluation: NSCLC

Dr. Benjamin Levy, Clinical Director at the Johns Hopkins Sidney Kimmel Cancer Center at the Sibley Memorial Hospital in Washington, D.C., presents a self-evaluation questions on non-small cell lung cancer.

Self-Evaluation: Breast Cancer

Dr. Shaheenah Dawood, consultant medical oncologist and lead of the oncology research program at the Comprehensive Cancer Center Mediclinic City Hospital in the United Arab Emirates, presents a self-evaluation question on the predictive and prognostic rule of pathological complete response attained in the treatment of breast cancer.

Self-Evaluation: Metastatic Breast Cancer

Dr. Aditya Bardia, attending physician at the Massachusetts General Hospital Cancer Center, presents a self-evaluation question on the treatment of metastatic breast cancer.

ASCO Guidelines: Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer Update

Dr. Gregory Riely, medical oncologist at Memorial Sloan Kettering Cancer Center in New York City, presents the ASCO Guideline update on Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer, published in the Journal of Clinical Oncology in August 2017.

Recently Approved Drugs: Nivolumab for Metastatic Colorectal Cancer

Dr. Matthew Yurgelun, assistant professor of medicine at Harvard Medical School and gastrointestinal medical oncologist at the Dana Farber Gastrointestinal Cancer Center and Cancer Genetics and Prevention Program, presents information on the recently approved nivolumab for the treatment of patients 12 years and older with mismatch repair deficient and microsatellite instability high metastatic colorectal cancer.

Self-Assessment: Metastatic Prostate Cancer

Dr. Janice Dutcher, Associate Director of the Cancer Research Foundation of New York and medical oncology co-chair of the NCI Renal Cancer Task Force, presents a self-assessment question on the treatment of castrate-resistant metastatic prostate cancer.

Recently Approved Drugs: Pembrolizumab for cHL

Dr. Christina Wiedl, director of the pediatric and young adult stem cell transplant program at Virginia Commonwealth University, presents information on the recently approved drug in oncology, keytruda for relapsed and refractory classical Hodgkin lymphoma in pediatric and young adult patients.

ASCO Guidelines: Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer

Dr. Josh Lauring, Assistant Professor of Oncology at the Sidney Kimmel Cancer Center at John's Hopkins, presents the joint ASCO/AMP Guideline on Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in cancer, published in the Journal of Molecular Pathology in January 2017.

ASCO Guidelines: Management of Small Renal Masses

Dr. Ornob Roy, Urologist with Carolinas Healthcare Systems, presents the ASCO Guideline on Management of Small Renal Masses, originally published in the Journal of Clinical Oncology in January 2017.